ConvaTec Group Plc (ConvaTec) is a medical products and technologies company that specializes in continence and critical care, ostomy care, infusion devices and advanced wound care. Its major products include wound dressings, skin care products, disposable infusion sets, urological catheters; and devices and accessories for people with ostomy, urinary continence, spinal cord injuries, diabetes, ulcers, multiple sclerosis, spina bifida and other disorders. ConvaTec offers products to hospitals, homecare agencies, pharmacies, insulin pump manufacturers and retail distributors in the homecare market directly and through a network of distributors. The company has presence in the Americas, Asia Pacific, Europe, the Middle East and Africa. ConvaTec is headquartered in Reading, Berkshire, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ConvaTec Group Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- ConvaTec Group Plc Company Overview
- ConvaTec Group Plc Company Snapshot
- ConvaTec Group Plc Pipeline Products and Ongoing Clinical Trials Overview
- ConvaTec Group Plc - Pipeline Analysis Overview
- Business Description
- ConvaTec Group Plc - Key Facts
- ConvaTec Group Plc - Major Products and Services
- ConvaTec Group Plc Pipeline Products by Development Stage
- ConvaTec Group Plc Ongoing Clinical Trials by Trial Status
- ConvaTec Group Plc Pipeline Products Overview
- Avelle 2.0
- Avelle 2.0 Product Overview
- Closed Loop Continuous Glucose Monitoring System
- Closed Loop Continuous Glucose Monitoring System Product Overview
- Esteem 2.0
- Esteem 2.0 Product Overview
- Extended Infusion Set
- Extended Infusion Set Product Overview
- GentleCath Air Female
- GentleCath Air Female Product Overview
- GentleCath Air Female Clinical Trial
- Infusion Set - Tandem Mobi
- Infusion Set - Tandem Mobi Product Overview
- Next Generation Hydrofiber
- Next Generation Hydrofiber Product Overview
- ConvaTec Group Plc - Key Competitors
- ConvaTec Group Plc - Key Employees
- ConvaTec Group Plc - Key Employee Biographies
- ConvaTec Group Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- ConvaTec Group Plc, Recent Developments
- Mar 22, 2023: ConvaTec Group Notice of Annual General Meeting
- Mar 09, 2023: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2022
- Mar 30, 2022: ConvaTec Group announces Annual Report and Accounts 2021 and Notice of AGM
- Mar 17, 2022: ConvaTec Group Announces Board Change
- Mar 08, 2022: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2021
- Mar 08, 2022: ConvaTec Group Annual Results for the twelve months ended 31 December 2021
- Jan 27, 2022: ConvaTec Group Announce Board Committee Changes
- Dec 09, 2021: Convatec Announces Chief Financial Officer succession
- Sep 23, 2021: ConvaTec selects Veeva Vault CDMS for biomarker study in wound infections
- Jul 30, 2021: ConvaTec Group Announces Interim Results for the six months ended 30 June 2021
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- ConvaTec Group Plc Pipeline Products and Ongoing Clinical Trials Overview
- ConvaTec Group Plc Pipeline Products by Equipment Type
- ConvaTec Group Plc Pipeline Products by Indication
- ConvaTec Group Plc Ongoing Clinical Trials by Trial Status
- ConvaTec Group Plc, Key Facts
- ConvaTec Group Plc, Major Products and Services
- ConvaTec Group Plc Number of Pipeline Products by Development Stage
- ConvaTec Group Plc Pipeline Products Summary by Development Stage
- ConvaTec Group Plc Ongoing Clinical Trials by Trial Status
- ConvaTec Group Plc Ongoing Clinical Trials Summary
- Avelle 2.0 - Product Status
- Avelle 2.0 - Product Description
- Closed Loop Continuous Glucose Monitoring System - Product Status
- Closed Loop Continuous Glucose Monitoring System - Product Description
- Esteem 2.0 - Product Status
- Esteem 2.0 - Product Description
- Extended Infusion Set - Product Status
- Extended Infusion Set - Product Description
- GentleCath Air Female - Product Status
- GentleCath Air Female - Product Description
- GentleCath Air Female - GentleCath Air Intermittent Catheter Smartwatch Real Life Pilot Study
- Infusion Set - Tandem Mobi - Product Status
- Infusion Set - Tandem Mobi - Product Description
- Next Generation Hydrofiber - Product Status
- Next Generation Hydrofiber - Product Description
- ConvaTec Group Plc, Key Employees
- ConvaTec Group Plc, Key Employee Biographies
- ConvaTec Group Plc, Other Locations
- ConvaTec Group Plc, Subsidiaries
- Glossary
- ConvaTec Group Plc Pipeline Products by Equipment Type
- ConvaTec Group Plc Pipeline Products by Development Stage
- ConvaTec Group Plc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M United Kingdom PLC
- Coloplast Corp
- Stryker Corp
- Hollister Inc
- Molnlycke Health Care AB
- Smith & Nephew Plc
- Ypsomed Holding AG
- Medline Industries Inc
